Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Patients Characteristics
0 citations
Hirak Der‐Torossian
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
195Publications signalées
3039Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Colorectal Cancer Treatments and StudiesCancer Treatment and PharmacologyLung Cancer Treatments and MutationsCancer Diagnosis and TreatmentGenetic factors in colorectal cancer
Les publications récentes
Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Generation of acquired resistance PDX model
0 citations
Supplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Characterization of acquired resistance in vitro models
0 citations
Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Patients Progression Cell Free DNA data
0 citations
Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
RW7213 cell lines sequencing analysis
0 citations
Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Oncoprint of baseline alterations in CRC patients who developed resistance to KRAS G12C and EGFR inhibitors
0 citations
Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
C106 cell lines single cell sequencing analysis
0 citations
Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
C106 resistant cells drug withdrawal and Patient #12 MSK-Impact data
0 citations
Supplementary Table 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Patients Longitudinal Cell Free DNA data
0 citations
Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Patients Progression Cell Free DNA data
0 citations
Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Generation of acquired resistance PDX model
0 citations
Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian et autres
Oncoprint of baseline alterations in CRC patients who developed resistance to KRAS G12C and EGFR inhibitors
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.